Literature DB >> 15964256

Thrombin mediated migration of osteogenic cells.

Jeffrey M Karp1, Tetsuya S Tanaka, Ron Zohar, Jaro Sodek, Molly S Shoichet, John E Davies, William L Stanford.   

Abstract

Given that thrombin is ubiquitously expressed at sites of vascular injury, and that osteogenic cells express receptors for thrombin, we questioned whether thrombin could attract osteogenic cells to a bony wound. Using a scratch wound assay, thrombin stimulated a significant increase in migration of osteogenic cultures of primary marrow cells. This effect was dependent on thrombin proteolytic activity; however, thrombin was unable to stimulate the migration of a more differentiated marrow-derived osteogenic cell line. To better understand the role of thrombin in osteoprogenitor migration, we developed an osteoprogenitor migration assay that combines a modified Boyden chamber with a bone nodule assay. Primary cells that migrated through the transwell filter in the presence of thrombin formed significantly more bone nodules compared to the condition without thrombin. This was not due to proliferation or differentiation effects of thrombin. In contrast, thrombin was unable to stimulate an increase in the number of nodules for the more differentiated osteogenic cell line. Thus, our results suggest that thrombin exhibits differential motogenic effects on osteogenic cells depending on their differentiation state. The cell migration/bone nodule assay described here is the first assay that can be specifically used to examine the effects of factors on the migration of osteoprogenitor cells, particularly those derived from primary populations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15964256     DOI: 10.1016/j.bone.2005.04.022

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  12 in total

Review 1.  Regulation of long-term repopulating hematopoietic stem cells by EPCR/PAR1 signaling.

Authors:  Shiri Gur-Cohen; Orit Kollet; Claudine Graf; Charles T Esmon; Wolfram Ruf; Tsvee Lapidot
Journal:  Ann N Y Acad Sci       Date:  2016-03-01       Impact factor: 5.691

2.  Systemic Mesenchymal Stromal Cell Transplantation Prevents Functional Bone Loss in a Mouse Model of Age-Related Osteoporosis.

Authors:  Jeffrey Kiernan; Sally Hu; Marc D Grynpas; John E Davies; William L Stanford
Journal:  Stem Cells Transl Med       Date:  2016-03-17       Impact factor: 6.940

3.  Angiogenic factor-enriched platelet-rich plasma enhances in vivo bone formation around alloplastic graft material.

Authors:  Eun-Seok Kim; Jae-Jin Kim; Eun-Jin Park
Journal:  J Adv Prosthodont       Date:  2010-03-31       Impact factor: 1.904

4.  Overexpression of H1 calponin in osteoblast lineage cells leads to a decrease in bone mass by disrupting osteoblast function and promoting osteoclast formation.

Authors:  Nan Su; Maomao Chen; Siyu Chen; Can Li; Yangli Xie; Ying Zhu; Yaozong Zhang; Ling Zhao; Qifen He; Xiaolan Du; Di Chen; Lin Chen
Journal:  J Bone Miner Res       Date:  2013-03       Impact factor: 6.741

5.  Osteogenic differentiation of mesenchymal stem cells promoted by overexpression of connective tissue growth factor.

Authors:  Jin-jing Wang; Feng Ye; Li-jia Cheng; Yu-jun Shi; Ji Bao; Huai-qiang Sun; Wei Wang; Peng Zhang; Hong Bu
Journal:  J Zhejiang Univ Sci B       Date:  2009-05       Impact factor: 3.066

6.  Improved bone healing by angiogenic factor-enriched platelet-rich plasma and its synergistic enhancement by bone morphogenetic protein-2.

Authors:  Eun-Jin Park; Eun-Seok Kim; Hans-Peter Weber; Robert F Wright; David J Mooney
Journal:  Int J Oral Maxillofac Implants       Date:  2008 Sep-Oct       Impact factor: 2.804

7.  PAR1 signaling regulates the retention and recruitment of EPCR-expressing bone marrow hematopoietic stem cells.

Authors:  Shiri Gur-Cohen; Tomer Itkin; Sagarika Chakrabarty; Claudine Graf; Orit Kollet; Aya Ludin; Karin Golan; Alexander Kalinkovich; Guy Ledergor; Eitan Wong; Elisabeth Niemeyer; Ziv Porat; Ayelet Erez; Irit Sagi; Charles T Esmon; Wolfram Ruf; Tsvee Lapidot
Journal:  Nat Med       Date:  2015-10-12       Impact factor: 53.440

8.  A portable chemotaxis platform for short and long term analysis.

Authors:  Chenjie Xu; Yuk Kee C Poh; Isaac Roes; Eoin D O'Cearbhaill; Mads Emil Matthiesen; Luye Mu; Seung Yun Yang; David Miranda-Nieves; Daniel Irimia; Jeffrey M Karp
Journal:  PLoS One       Date:  2012-09-17       Impact factor: 3.240

Review 9.  Relationship between heterotopic ossification and traumatic brain injury: Why severe traumatic brain injury increases the risk of heterotopic ossification.

Authors:  Huan Huang; Wen-Xiang Cheng; Yi-Ping Hu; Jian-Hai Chen; Zheng-Tan Zheng; Peng Zhang
Journal:  J Orthop Translat       Date:  2017-11-14       Impact factor: 5.191

Review 10.  Research progress in the mechanism of effect of PRP in bone deficiency healing.

Authors:  Ning Zhang; Yong-Ping Wu; Sheng-Jun Qian; Chong Teng; Shuai Chen; Hang Li
Journal:  ScientificWorldJournal       Date:  2013-04-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.